Global TB Programme, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland.
Global TB Programme, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland.
Clin Chest Med. 2019 Dec;40(4):755-762. doi: 10.1016/j.ccm.2019.07.005.
The World Health Organization Supranational TB Reference Laboratory Network (SRLN) has served as the backbone for TB drug-resistance surveillance and diagnosis since 1994 and remains a key WHO programme for antimicrobial resistance (AMR) surveillance at the global level. SRLN is a great technical resource for proficiency testing to ensure accuracy of drug-susceptibility testing, scale-up, capacity development in countries and provides unique support to the reliable detection of drug resistance. Technical assistance from individual SRLs has been supported by a variety of mechanisms but funding for the SRLN has become increasingly challenging.
世界卫生组织超国家结核病参考实验室网络（SRLN）自 1994 年以来一直是结核病耐药性监测和诊断的骨干力量，仍然是世卫组织在全球一级开展抗微生物药物耐药性（AMR）监测的一个主要方案。SRLN 是能力验证的重要技术资源，可确保药物敏感性测试的准确性、扩大规模、国家能力发展，并为可靠检测耐药性提供独特支持。个别 SRL 的技术援助得到了各种机制的支持，但 SRLN 的供资越来越具有挑战性。
